Jessica Hagen
Daryl Tol, president of General Catalyst’s Health Assurance Transformation Company (HATCo), shares an update on the current state of the venture firm’s healthcare system.
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.
At Future of Health’s invitation-only event, former CDC Director Dr. Rochelle Walensky sat down with MobiHealthNews to discuss the potential and challenges of AI in healthcare.
The SnkeXR augmented reality glasses are designed for clinical use and include tools and an open platform to help companies bring AR technology into healthcare workflows.
The partnership allows Sleep Cycle users to access Dreem Health’s network of sleep specialists for evaluation and treatment of sleep disorders directly through the app.
Calm users identified as needing high-acuity mental healthcare will be connected with LifeStance’s virtual behavioral health specialists.
The AI voice tool maker will power WellSky’s AI ambient listening to generate clinical notes within its EHR for behavioral health, long-term acute care and rehab facilities.
Eli Lilly and Company says the partnership will result in the development of the most powerful supercomputer owned by a pharmaceutical company.
The tech giant launches a public preview of its personalized health coach, which helps users achieve fitness goals, analyze sleep and get answers to health questions.